Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Mehr lesenEducation:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Dr. Antonia Artigues-Barcelo is an Internal Medicine Consultant with more than 20 years of experience in the field of Internal Medicine.
After completing her Medical Degree from Universitat Autonoma in Barcelona, Spain, she acquired her Specialisation in Internal Medicine from Hospital Universitari Son Dureta and Hospital Clinic in Barcelona, both in Spain. She has extensive experience in Internal Medicine in inpatient and outpatient settings.
Before moving to the UAE, she was practicing in both private and government Hospitals in Spain, where she implemented different projects, including Autoimmune Systemic Diseases Unit, Palliative Care Unit, and a multidisciplinary management program of hip fractures in older patients. She was also the HOD in Internal Medicine Department.
Since she moved to the UAE, she has been working as an Internal Medicine Consultant in well-known Clinics and Hospitals in Dubai. She has also been an Adjunct Associated Professor at Mohammed Bin Rashid University (MBRU).
Her scope of expertise includes general internal medicine conditions, gastrointestinal disorders, respiratory diseases, anaemias, thyroid conditions, as well as, infection diseases, autoimmune systemic conditions and prevention, detection, and treatment of cardiovascular risk factors, such as hypertension, diabetes, or dyslipidaemia. She also carries out general check-ups.
She is a member of the Spanish Medical Council and the Internal Medicine Spanish Association, as well as, member of Middle East and North Africa Stroke Organization.
EXPERTISE:
Dr. Antonia Artigues-Barcelo is an Internal Medicine Consultant with more than 20 years of experience in the field of Internal Medicine.
After completing her Medical Degree from Universitat Autonoma in Barcelona, Spain, she acquired her Specialisation in Internal Medicine from Hospital Universitari Son Dureta and Hospital Clinic in Barcelona, both in Spain. She has extensive experience in Internal Medicine in inpatient and outpatient settings.
Before moving to the UAE, she was practicing in both private and government Hospitals in Spain, where she implemented different projects, including Autoimmune Systemic Diseases Unit, Palliative Care Unit, and a multidisciplinary management program of hip fractures in older patients. She was also the HOD in Internal Medicine Department.
Since she moved to the UAE, she has been working as an Internal Medicine Consultant in well-known Clinics and Hospitals in Dubai. She has also been an Adjunct Associated Professor at Mohammed Bin Rashid University (MBRU).
Her scope of expertise includes general internal medicine conditions, gastrointestinal disorders, respiratory diseases, anaemias, thyroid conditions, as well as, infection diseases, autoimmune systemic conditions and prevention, detection, and treatment of cardiovascular risk factors, such as hypertension, diabetes, or dyslipidaemia. She also carries out general check-ups.
She is a member of the Spanish Medical Council and the Internal Medicine Spanish Association, as well as, member of Middle East and North Africa Stroke Organization.
EXPERTISE:
Medical Fields of Special Interest and Activities
Mood Disorders (Bipolar Disorder, Depressive Disorder, Dysthymic Disorder)
Attention Deficit Disorder With Hyperactivity
Autism Spectrum Disorder
Suicide
Anxiety Disorder
Post Traumatic Stress Disorder
Eating Disorders
Sexual and Physical Abuse
Forensic Evaluation
Education and Experience
Liv Hospital Ulus Psychiatry Department
Erenköy Psychiatric Training and Research Hospital Child Psychiatry Clinic -Founder- 2015-2017
Associate Professor On Dokuz Mayıs University Medical Faculty Child and Adolescent Psychiatry Department, Samsun 2011-2015
Assistant Professor Ondokuz Mayıs University Medical Faculty Child and Adolescent Psychiatry Department, Founder of the Department -Samsun 2003-2011
Kocaeli State Hospital, İzmit 2002-2003
Attending Physcian, Behçet Uz Child Hospital, İzmir 2002
Researcher Doctor Ege University Medical Faculty Child and Adolescent Psychiatry Department, İzmir 1997-2002
Dr. Susurluk State Hospital 1995-1997
Dr. Artvin Mother and Child Care and Family Planning Center, Artvin 1993-1995
Memberships
Turkish Medical Association
Child and Adolescent Mental Health Association, 2011-2013 Proficiency Executive Committee, Proficient Examination Sub Commission Member
Samsun Branch of Turkey Psychiatry Association
Mehr lesenMedical Fields of Special Interest and Activities
Mood Disorders (Bipolar Disorder, Depressive Disorder, Dysthymic Disorder)
Attention Deficit Disorder With Hyperactivity
Autism Spectrum Disorder
Suicide
Anxiety Disorder
Post Traumatic Stress Disorder
Eating Disorders
Sexual and Physical Abuse
Forensic Evaluation
Education and Experience
Liv Hospital Ulus Psychiatry Department
Erenköy Psychiatric Training and Research Hospital Child Psychiatry Clinic -Founder- 2015-2017
Associate Professor On Dokuz Mayıs University Medical Faculty Child and Adolescent Psychiatry Department, Samsun 2011-2015
Assistant Professor Ondokuz Mayıs University Medical Faculty Child and Adolescent Psychiatry Department, Founder of the Department -Samsun 2003-2011
Kocaeli State Hospital, İzmit 2002-2003
Attending Physcian, Behçet Uz Child Hospital, İzmir 2002
Researcher Doctor Ege University Medical Faculty Child and Adolescent Psychiatry Department, İzmir 1997-2002
Dr. Susurluk State Hospital 1995-1997
Dr. Artvin Mother and Child Care and Family Planning Center, Artvin 1993-1995
Memberships
Turkish Medical Association
Child and Adolescent Mental Health Association, 2011-2013 Proficiency Executive Committee, Proficient Examination Sub Commission Member
Samsun Branch of Turkey Psychiatry Association
Dr. Ramazan Kılıç born in 1997 Şanlıurfa, Turkey. He finished he's middle school and high school education in Şanlıurfa. He finished Malatya University Faculty of Dentistry
attended conferences
Necmettin Erbakan University 2nd International Dentistry Congress
Selcuk University 3rd International Congress of Innovative Dentistry TDB
22nd International Dentistry Congress To ITI Turkey & Azerbaijan Congress
Mehr lesenDr. Ramazan Kılıç born in 1997 Şanlıurfa, Turkey. He finished he's middle school and high school education in Şanlıurfa. He finished Malatya University Faculty of Dentistry
attended conferences
Necmettin Erbakan University 2nd International Dentistry Congress
Selcuk University 3rd International Congress of Innovative Dentistry TDB
22nd International Dentistry Congress To ITI Turkey & Azerbaijan Congress
Memberships
Prizes, awards and recognition
International experience
Memberships
Prizes, awards and recognition
International experience
He graduated in Medicine and Surgery from the University of Padua, where, in 1996, he obtained the specialization in Endocrinology, Diabetology and Metabolic Diseases. In 1994 he specialized in Metabolic Diseases from the San Bortolo University Hospital in Vicenza. Engaged in research activities in the areas of use of engineered tissues and growth factors for tissue regeneration, new technologies in the field of conservative surgical treatment, and extreme percutaneous revascularization protocols. He has been chairman of several international courses on Diabetic Foot and Charcot Foot and he is a member of the Editorial Board of the journal "Diabetic Foot and Ankle", and of the European Diabetic Foot Study Group (DFSG).
Author of over 100 scientific publications and about 300 speeches at international congresses, including several editions of the National Congress of the Diabetes Doctors Association or the Italian Journal of Diabetology.
Awarded with "Ilizarov Award of Excellence" at the International External Fixation Symposium, 2018; -“Paul Brand Memorial Lecture” Award in 2016.
Mehr lesenHe graduated in Medicine and Surgery from the University of Padua, where, in 1996, he obtained the specialization in Endocrinology, Diabetology and Metabolic Diseases. In 1994 he specialized in Metabolic Diseases from the San Bortolo University Hospital in Vicenza. Engaged in research activities in the areas of use of engineered tissues and growth factors for tissue regeneration, new technologies in the field of conservative surgical treatment, and extreme percutaneous revascularization protocols. He has been chairman of several international courses on Diabetic Foot and Charcot Foot and he is a member of the Editorial Board of the journal "Diabetic Foot and Ankle", and of the European Diabetic Foot Study Group (DFSG).
Author of over 100 scientific publications and about 300 speeches at international congresses, including several editions of the National Congress of the Diabetes Doctors Association or the Italian Journal of Diabetology.
Awarded with "Ilizarov Award of Excellence" at the International External Fixation Symposium, 2018; -“Paul Brand Memorial Lecture” Award in 2016.